检索结果：
返回 248 结果。
排序：
期刊
- 作者：
Li Fan ，Xiao Yang ，Huaying Shen ，Menghua Chen ，Hao Zhang ，Zhaohui Ni ，Hongli Lin ，Hongtao Yang ，Qinkai Chen ，Hongyu Chen ，Gengru Jiang ，Jianqin Wang ，Jiuyang Zhao ，Zhuxing Sun ，Aiping Yin ，Aili Jiang ，Yun Li ，Hui Peng ，Nan Chen ，Chuanming Hao ，Yaozhong Kong ，Rong Rong ，Jie Li ，Xia Zou ，Haotian Luo ，Jiaqi Qian ，Xueqing Yu （ 1Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China 2Department of Nephrology, The First Affiliated Hospital, Sun Yat‐sen University, NHC Key Laboratory of Nephrology (Sun Yat‐sen University), Guangdong Provincial Key Laboratory of Nephrology, Guangzhou, China 3Department of Nephrology, The Second Affiliated Hospital of Soochow University, Suzhou, China 4Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, China 5Department of Nephrology, The Third Xiangya Hospital of Central South University, Changsha, China 6Department of Nephrology, Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China 7Department of Nephrology, The First Affiliated Hospital of Dalian Medical University, Dalian, China 8Department of Nephrology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China 9Department of Nephrology, The First Affiliated Hospital of Nanchang University, Nanchang, China 10Department of Nephrology, Hangzhou Traditional Chinese Medicine Hospital, Hangzhou, China 11Department of Nephrology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China 12Department of Nephrology, Lanzhou University Second Hospital, Lanzhou, China 13Department of Nephrology, the Second Affiliated Hospital of Dalian Medical University, Dalian, China 14Department of Nephrology, Wuxi Pepole's Hospital, Wuxi, China 15Department of Nephrology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China 16Department of Nephrology, The Second Hospital of Tianjin Medical University, Tianjin, China 17Department of Nephrology, Jiangxi Provincial People's Hospital, Nanchang, China 18Department of Nephrology, The Third Affiliated Hospital of Sun Yat‐sen University, Guangzhou, China 19Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China 20Department of Nephrology, Huashan Hospital, Fudan University, Shanghai, China 21Department of Nephrology, The First People's Hospital of Foshan, Foshan, China 22Global Health Research Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China 23School of Mathematical Sciences, Xiamen University, Xiamen, China ） - 出处： Medicine Advances 2024 Vol.2 No.2 P112-122
- 关键词： end‐stage kidney disease peritoneal dialysis hemodialysis patient survival
- 摘要： Background Peritoneal dialysis and conventional in‐center hemodialysis are treatment options for patients with end‐stage kidney disease . However, t
- 作者：
Li Wang ，Li Zuo ，Ming Shi ，Leyi Gu ，Kunling Ma ，Pei Wang ，Yu Wang ，Qun Luo ，Menghua Chen ，Ping Zhang ，Hongli Jiang ，Guisen Li ，Weifeng Zhang ，Yingxue Cathy Liu ，Qing Zhao （ 1Department of Nephrology and Institute of Nephrology, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Sichuan Clinical Research Centre for Kidney Diseases, Chengdu, Sichuan, China;Correspondence: Li Wang, Department of Nephrology and Institute of Nephrology, Sichuan Provincial People's Hospital, 32# W. Sec 2, 1st Ring Rd., Chengdu, Sichuan Province, P.R. China.;2Department of Nephrology, Peking University People’s Hospital, Beijing, China;3Department of Nephrology, Blood Purification Center, Renmin Hospital of Wuhan University, Wuhan, China;4Molecular Cell Lab for Kidney Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China;Department of Nephrology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China;Shanghai Peritoneal Dialysis Research Center, Uremia Diagnosis and Treatment Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China;5Department of Nephrology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;6Department of Nephrology, Blood Purification Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;7Department of Nephrology, the First Affiliated Hospital of Nanchang University, Nanchang, China;8Kidney Disease Center, Ningbo No. 2 Hospital, Ningbo, China;9Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, China;10Kidney Disease Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;11Blood Purification Center, the First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, China;12Department of Nephrology and Institute of Nephrology, Sichuan Provincial People’s Hospital, School of Medicine, University of Electronic Science and Technology of China, Sichuan Clinical Research Centre for Kidney Diseases, Chengdu, Sichuan, China;13Clinical Science, Shanghai Alebund Pharmaceuticals Limited, Shanghai, China;14Biometrics, Shanghai Alebund Pharmaceuticals Limited, Shanghai, China ） - 出处： Kidney International Reports 2025 Vol.10 No.4 P1143-1151
- 关键词： dialysis end-stage kidney disease hyperphosphatemia phosphate transporter
- 摘要： Introduction: Hyperphosphatemia in patients undergoing dialysis is not well-controlled. AP306 is a pan-inhibitor of phosphate transporters, designed t
期刊
- 作者：
Lu Li ，Hongxia Zhang ，Botao Zhang ，Fangyuan Yang ，Mengting Wang ，Wenlong Qiu ，Lina Fu ，Menghua Chen ，Na Tian （ Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China Ningxia Nephrology Disease Clinical Research Center, Yinchuan, Ningxia, China Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China Ningxia Nephrology Disease Clinical Research Center, Yinchuan, Ningxia, China Department of Cardiology, Hospital of Cardio-cerebrovascular disease, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China Department of Nephrology and Diabetes, Baoji Central Hospital, Baoji, Shaanxi, China The First Clinical Medical School of Ningxia Medical University, General Hospital of Ningxia, Yinchuan, Ningxia, China Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China Ningxia Nephrology Disease Clinical Research Center, Yinchuan, Ningxia, China Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China Ningxia Nephrology Disease Clinical Research Center, Yinchuan, Ningxia, China Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China Ningxia Nephrology Disease Clinical Research Center, Yinchuan, Ningxia, China Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China Ningxia Nephrology Disease Clinical Research Center, Yinchuan, Ningxia, China Na Tian, Department of Nephrology, General Hospital of Ningxia Medical University, No. 804 Shengli Road, Yinchuan 750004, Ningxia, China. ） - 出处： Therapeutic Apheresis and Dialysis 2025 Vol.29 No.3 P479-490
- 关键词： all-cause mortality cardiovascular mortality peritoneal dialysis time-averaged serum uric acid
- 摘要： Background The relationship between time-averaged serum uric acid levels and prognosis in peritoneal dialysis patients are rarely discussed. Methods
期刊
- 作者：
Shengnan Zhou ，Yinyin Yan ，Rui Chu ，Na Chen ，Li Wang ，Hongxia Zhang ，Yan Wang ，Mengting Wang ，Li Na ，Hongyan Ren ，Menghua Chen ，Philip Kam-Tao Li ，null ，Na Tian （ 1Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, 750004, China;2The Second Affiliated Hospital of Xi’an Medical University, Xi’an, Shanxi, China;3BioBank of General Hospital of Ningxia Medical University, Yinchuan, Ningxia, 750004, China;4Shanghai Mobio Biomedical Technology Co. Ltd., Shanghai, 201100, China;5Department of Medicine and Therapeutics, Carol and Richard Yu Peritoneal Dialysis Research Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, China ） - 出处： Scientific Reports 2024 Vol.14
- 摘要： The gut microbiota alterations interact with the pathogenesis and progression of chronic kidney disease . Probiotics have received wide attention as a
期刊
- 作者：
Li, Yanmei ，Feng, Xiaonan ，Chen, Na ，Song, Shuhua ，Yu, Min ，Wang, Yan ，Zhang, Hongxia ，Wang, Li ，Chen, Menghua ，Tian, Na （ 1Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan, China 2Ningxia Clinical Research Center of Kidney Disease, Yinchuan, China ） - 出处： Renal Failure 2024 Vol.46 No.2 P1-12
- 关键词： hyperparathyroidism infection mortality Peritoneal dialysis prognosis risk factors severe
- 摘要： Secondary hyperparathyroidism can progress to severe SHPT , which affects the survival rate and quality of life of patients. This retrospective cohor
- 作者：
栾凤武 ，冯晓楠 ，陈娜 ，彭佳楠 ，田娜 ，陈孟华 （ 1宁夏医科大学总医院肾脏内科；2宁夏肾脏疾病临床医学研究中心 ） - 出处： 宁夏医学杂志 2025 第47卷 第2期 P151-154
- 关键词： 血液透析 腹膜透析 认知障碍
- 摘要： 目的 对比分析血液透析与腹膜透析患者认知障碍发生率及相关影响因素。方法 纳入维持性血液透析患者60例,持续不卧床腹膜透析患者62例作为研究对象。对维持性透析患者认知功能的评估采用蒙特利尔认知评估量表,分析2种透析方式患者认知障碍的发生率及其危险因素。结果 CI在MHD组和CAPD组的发生率分别为56
-
被引量：1
- 作者：
杨爽 ，徐梦 ，田娜 ，陈孟华 （ 1宁夏医科大学总医院肾脏内科；2宁夏肾脏疾病临床医学研究中心 ） - 出处： 宁夏医学杂志 2025 第47卷 第1期 P80-83
- 关键词： 吸烟 透析人群 预后影响
- 摘要： 终末期肾病是日益严重的社会公共卫生问题，从1990年到2013年，全球因ESRD死亡的人数增加了134.6%。中心血液透析和家庭腹膜透析是终末期肾脏病最常见的2种透析治疗形式。接受透析治疗的患者最常见的死亡原因有心血管疾病、感染和癌症。吸烟是有害健康的公共卫生问题，根据世界卫生组织的数据，吸烟每年造
- 作者：
Xiaoling Zhou ，Jianhua Ye ，Xiaoyan Guo ，Menghua Chen （ 1Nephrology Department, General Hospital of Ningxia Medical University, Ningxia Clinical Research Center for Kidney Disease, Yinchuan, Ningxia, 750004, China ） - 出处： Heliyon 2024 Vol.10 No.8 Pe29488
- 关键词： Renal insufficiency Corbrin capsule Meta-analysis
- 摘要： Objective At present, there remains controversy regarding the clinical efficacy of Corbrin capsules in the treatment of renal insufficiency . A meta-
- 作者：
殷效龙 ，叶建华 ，张汀 ，陈孟华 （ 宁夏医科大学总医院肾脏内科 ） - 出处： 宁夏医学杂志 2024 第46卷 第1期 P12-15
- 关键词： 血液透析 自体动静脉内瘘 早期失功 危险因素
- 摘要： 目的 探讨血液透析患者自体动静脉内瘘早期失功的相关危险因素，为降低自体动静脉内瘘失功的发生提供依据。方法 选择收治的拟行血液透析首次建立自体动静脉内瘘手术的92例患者，根据术后1个月，未行透析前是否发生自体动静脉内瘘早期失功分成通畅组和失功组,收集2组临床资料，采用多因素分析法分析自体动静脉内瘘早期
-
被引量：6
期刊
- 作者：
Ping Zhang ，Yan Jiang ，Chunping Xu ，Linghui Zhou ，Hongguang Zheng ，Deqiong Xie ，Minghao Guo ，Xiangyang Huang ，Guoyuan Lu ，Hongli Jiang ，Hongyu Qiu ，Bicheng Liu ，Shaomei Li ，Qinkai Chen ，Yu'ou Xia ，Bengui Sun ，Xiao Yang ，Shiying Zhang ，Shutong Du ，Mindan Sun ，Menghua Chen ，Aimin Zhong ，Xiaoling Wang ，Zhanzheng Zhao ，Hua Zhou ，Guisen Li ，Yueqin Ren ，Qun Luo ，Aicheng Yang ，Ping Luo ，Shuifu Tang ，Chengyun Xu ，Qin Wang ，Xiaoxia Wang ，Tiekun Yan ，Wei He ，Shuguang Qin ，Weili Zhang ，Lu Lv ，Cheng Wang ，Hong Liu ，Jing Li ，Qiong Wu ，Chao Pan ，Chuan Li ，Liangliang He ，Jianghua Chen （ 1Kidney Disease Center, The First Affiliated Hospital, Medical School of Zhejiang University, Hangzhou, China;2Ping Zhang and Yan Jiang contribute equally to this study.;3The Department of Nephrology, The First Affiliated Hospital of Xiamen University, Xiamen, China;4The Department of Nephrology, General Hospital of Northern Theater Command, Shengyang, China;5The Department of Nephrology, The Second People's Hospital of Yibin, Yibin, China;6The Department of Nephrology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China;7The Department of Nephrology, Liuzhou Worker's Hospital, Liuzhou, China;8The Department of Nephrology, The First Affiliated Hospital of Soochow University, Suzhou, China;9The Department of Blood Purification, The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China;10The Department of Nephrology, West China Hospital of Sichuan University, Chengdu, China;11The Institute of Nephrology, Zhongda Hospital Southeast University, Nanjing, China;12The Department of Nephrology, The Second Hospital of HeBei Medical University, Shijiazhuang, China;13The Department of Nephrology, The First Affiliated Hospital of Nanchang University, Nanchang, China;14The Department of Nephrology, Siping Central People's Hospital, Siping, China;15The Department of Nephrology, The Second People's Hospital of Hefei, Hefei, China;16The Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Zhuhai, China;17The Department of Nephrology, Jilin Province People's Hospital, Changchun, China;18The Department of Nephrology, Cangzhou People's Hospital, Cangzhou, China;19The Department of Nephrology, The First Bethune Hospital of Jilin University, Changchun, China;20The Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuang, China;21The Department of Nephrology, People's Hospital of Jiangxi Province, Nanchang, China;22The Department of Nephrology, Lanzhou University Second Hospital, Lanzhou, China;23The Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China;24The Department of Nephrology, Shengjing Hospital of China Medicine University, Shengyang, China;25The Department of Nephrology, Sichuan Academy of Medical Sciences – Sichuan Provincial People's Hospital (SAMSPH), Chengdu, China;26The Department of Nephrology, LinYi People's Hospital, Linyi, China;27The Department of Nephrology, Hwamei Hospital, University of Chinese Academy of Sciences, China;28The Department of Nephrology, Wuyi Hospital of T.C.M, Jiangmen City (Affiliated Jiangmen TCM Hospital of Jinan University), China;29The Department of Nephrology, The Second Norman Bethune Hospital of Jilin University, Changchun, China;30The Department of Nephrology, The First Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China;31The Department of Nephrology, The Second Affiliated Hospital of Nanchang University, Nanchang, China;32The Department of Nephrology, Shanghai Fengxian Center Hospital, Shanghai, China;33The Department of Nephrology, Tong Ren Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China;34The Department of Nephrology, Tianjin Medical University General Hospital, Tianjin, China;35The Department of Nephrology, Traditional Chinese Medical Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China;36The Department of Nephrology, Guangzhou First People's Hospital, Guangzhou, China;37The Department of Nephrology, The First Hospital of Qiqihar, Qiqihar, China;38The Department of Nephrology, The First Affiliated Hospital/The First Clinical Medicine School of Guangdong Pharmaceutical University, Guangzhou, China;39The Department of Nephrology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China;40The Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China;41The Department of Nephrology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China;42Hansoh Pharmaceutical Group Co, Ltd, Shanghai, China ） - 出处： eClinicalMedicine 2023 Vol.65 P102273
- 关键词： Anemia Chronic kidney disease Dialysis Epoetin alfa Pegmolesatide
- 摘要： Background Pegmolesatide, a synthetic peptide-based erythropoietin receptor agonist, is being evaluated as an alternative to epoetin alfa for treatin